SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-15-009892
Filing Date
2015-02-17
Accepted
2015-02-17 14:42:56
Documents
1
Group Members
KLEINER PERKINS CAUFIELD & BYERS IX-A, L.P.KLEINER PERKINS CAUFIELD & BYERS IX-B, L.P.KLEINER PERKINS CAUFIELD & BYERS X-B, L.P.KPCB IX ASSOCIATES, LLCKPCB X ASSOCIATES, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v401787_sc13ga.htm SC 13G/A 83781
  Complete submission text file 0001144204-15-009892.txt   85377
Mailing Address
Business Address 2750 SAND HILL RD MENLO PARK CA 94025
KLEINER PERKINS CAUFIELD & BYERS X A LP (Filed by) CIK: 0001118829 (see all company filings)

IRS No.: 943365493 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87623 | Film No.: 15621195
SIC: 2834 Pharmaceutical Preparations